NCT00223496View on ClinicalTrials.gov

12- Week Open Label Treatment of Refractory Bipolar Depression

PHASE4CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions

Bipolar Disorder

Interventions

DRUG

Aripiprazole

Aripiprazole5mg - 30mg, every day (QD), for 12 weeks.

Trial Locations (1)

78229

Univ of Texas Helath Science Center at San Antonio, San Antonio

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

The University of Texas Health Science Center at San Antonio

OTHER